S2m Lifescience Private Limited, a active private limited company, was established on 17 February 2020 in Bhubaneswar, Orissa, India. Engaging in drug formulation & development within the professional, scientific and technical sector, it holds CIN: U24290OR2020PTC032719. Registered under ROC Roc Cuttack. it is unlisted. It has an authorized capital of ₹1.00 M and a paid-up capital of ₹0.10 M.
Formerly known as Reseapro Pharma Private Limited. It upholds a compliant status. Employing 1 professional, Its leadership includes Mukesh Kumar Das (Director), Tanmaya Mohapatra (Director). Past directors included Sachidananda Pattanaik, Laxmidhar Besra. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at Unit No-203, 2Nd Floor (Incubation), Plot No-330 B, Khata No-91, Ocac Tower, Acharya Vihar, Bhubaneswar, Orissa, 751013.
U24290OR2020PTC032719
032719
17 February 2020
₹1.00 M
₹0.10 M
Roc Cuttack
Unlisted
Active
Explore comprehensive insights into S2m Lifescience Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Mukesh Kumar Das | Director | 10 Jun 2021 | Current |
| Tanmaya Mohapatra | Director | 17 Feb 2020 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 10 Jun 2021 | Past |
| Pramod Abcsdd | Director | 10 Jun 2021 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
S2M Lifescience Private Limited, for the financial year ended 2022, experienced no change in revenue, with a 0% increase. The company also saw a substantial improvement in profitability, with a 67.71% increase in profit. The company's net worth observed a substantial decline by a decrease of 35.03%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
Unlock access to S2M Lifescience's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Reveal ownership structures and financial performance - Get instant access now!
There are no open charges registered against the company as per our records.
S2M Lifescience has a workforce of 1 employees as of Apr 07, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of S2M Lifescience, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped S2M Lifescience's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
The activity S2M Lifescience Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was completed.
S2M Lifescience Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Cuttack. was recorded as a recent event.
Mukesh Kumar Das was appointed as a Director was appointed as a Director on 10 Jun 2021 & has been associated with this company since 4 years 5 months . was recorded as a recent event.
Tanmaya Mohapatra was appointed as a Director was appointed as a Director on 17 Feb 2020 & has been associated with this company since 5 years 9 months . was recorded as a recent event.
The activity S2M Lifescience Private Limited was registered on 17 Feb 2020 with Roc Cuttack & aged 5 years 9 months as per MCA records. was completed.
The CIN of S2m Lifescience Private Limited is U24290OR2020PTC032719.
S2m Lifescience Private Limited is headquartered at Unit No-203, 2Nd Floor (Incubation), Plot No-330 B, Khata No-91, Ocac Tower, Acharya Vihar, Bhubaneswar, Orissa, 751013.
S2m Lifescience Private Limited was incorporated on 17 February 2020.
The current directors of S2m Lifescience Private Limited are
The primary industry of S2m Lifescience Private Limited is Professional, Scientific And Technical.
S2m Lifescience Private Limited is unlisted.
The authorized capital of S2m Lifescience Private Limited is ₹1.00 M, and the paid-up capital is ₹0.10 M.
The compliance status of S2m Lifescience Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX